Clinical Trial Update: A Phase I Study of Weekly Gemcitabine in Combination With Infusional Fluorodeoxyuridine and Oral Calcium Leucovorin in Adult Cancer Patients [Phase 1]

View source ↗

Summary

Phase I study evaluating weekly gemcitabine combined with infusional fluorodeoxyuridine and oral calcium leucovorin in adult cancer patients; the trial has been…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer

Drugs mentioned

• Gemzar (gemcitabine)
• calcium leucovorin (calcium leucovorin)
• fluorodeoxyuridine (fluorodeoxyuridine)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Neoplasms | Phase 1 | Status: COMPLETED